Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Current Assets (2016 - 2025)

CV Sciences' Current Assets history spans 14 years, with the latest figure at $5.1 million for Q3 2025.

  • For Q3 2025, Current Assets fell 24.47% year-over-year to $5.1 million; the TTM value through Sep 2025 reached $5.1 million, down 24.47%, while the annual FY2024 figure was $6.2 million, 21.35% down from the prior year.
  • Current Assets for Q3 2025 was $5.1 million at CV Sciences, down from $5.9 million in the prior quarter.
  • Across five years, Current Assets topped out at $17.5 million in Q1 2021 and bottomed at $5.1 million in Q3 2025.
  • The 5-year median for Current Assets is $8.5 million (2023), against an average of $10.1 million.
  • The largest annual shift saw Current Assets tumbled 43.18% in 2021 before it fell 11.73% in 2025.
  • A 5-year view of Current Assets shows it stood at $14.2 million in 2021, then decreased by 21.54% to $11.1 million in 2022, then fell by 28.68% to $7.9 million in 2023, then decreased by 21.35% to $6.2 million in 2024, then fell by 18.36% to $5.1 million in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Current Assets are $5.1 million (Q3 2025), $5.9 million (Q2 2025), and $6.0 million (Q1 2025).